- Home
- TGT vs TAK Comparison
TGT vs TAK Comparison
Compare TGT & TAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TGT
- TAK
- Stock Information
- Founded
- TGT 1902
- TAK 1781
- Country
- TGT United States
- TAK Japan
- Employees
- TGT N/A
- TAK N/A
- Industry
- TGT Department/Specialty Retail Stores
- TAK Biotechnology: Pharmaceutical Preparations
- Sector
- TGT Consumer Discretionary
- TAK Health Care
- Exchange
- TGT Nasdaq
- TAK Nasdaq
- Market Cap
- TGT 55.3B
- TAK 44.4B
- IPO Year
- TGT N/A
- TAK N/A
- Fundamental
- Price
- TGT $93.97
- TAK $15.03
- Analyst Decision
- TGT Buy
- TAK
- Analyst Count
- TGT 28
- TAK 0
- Target Price
- TGT $118.00
- TAK N/A
- AVG Volume (30 Days)
- TGT 8.3M
- TAK 2.2M
- Earning Date
- TGT 05-21-2025
- TAK 05-08-2025
- Dividend Yield
- TGT 4.76%
- TAK 3.92%
- EPS Growth
- TGT 2.04
- TAK N/A
- EPS
- TGT 9.10
- TAK 0.45
- Revenue
- TGT $105,881,000,000.00
- TAK $30,595,075,281.00
- Revenue This Year
- TGT $1.54
- TAK $1.01
- Revenue Next Year
- TGT $2.65
- TAK $1.04
- P/E Ratio
- TGT $10.33
- TAK $64.83
- Revenue Growth
- TGT N/A
- TAK 7.45
- 52 Week Low
- TGT $87.35
- TAK $12.58
- 52 Week High
- TGT $167.40
- TAK $15.43
- Technical
- Relative Strength Index (RSI)
- TGT 44.40
- TAK 60.23
- Support Level
- TGT $90.60
- TAK $14.51
- Resistance Level
- TGT $97.77
- TAK $14.75
- Average True Range (ATR)
- TGT 2.70
- TAK 0.21
- MACD
- TGT -0.05
- TAK 0.09
- Stochastic Oscillator
- TGT 27.18
- TAK 99.66
About TGT Target Corporation
Target serves as the nation's seventh-largest retailer, with its strategy predicated on delivering a gratifying in-store shopping experience and a wide product assortment of trendy apparel, home goods, and household essentials at competitive prices. Target's upscale and stylish image began to carry national merit in the 1990s—a decade in which the brand saw its top line grow threefold to almost $30 billion—and has since cemented itself as a leading US retailer.Today, Target operates over 1,950 stores in the United States, generates over $100 billion in sales, and fulfills over 2 billion customer orders annually. The firm's vast footprint is typically concentrated in urban and suburban markets as the firm seeks to attract a more affluent consumer base.
About TAK Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.6 trillion in fiscal 2024. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with over 50% derived from the US, 20% from Japan, 20% from Europe and Canada.